Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice

Standard

Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice. / Kaul, M G; Weber, O; Heinen, U; Reitmeier, A; Mummert, T; Jung, C; Raabe, N; Knopp, T; Ittrich, H; Adam, G.

in: ROFO-FORTSCHR RONTG, Jahrgang 187, Nr. 5, 05.2015, S. 347-52.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{065069e25e284e0caff7002268ecd65e,
title = "Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice",
abstract = "PURPOSE: Magnetic particle imaging (MPI) is a new radiologic imaging modality. For the first time, a commercial preclinical scanner is installed. The goal of this study was to establish a workflow between MPI and magnetic resonance imaging (MRI) scanners for a complete in vivo examination of a mouse and to generate the first co-registered in vivo MR-MP images.MATERIALS AND METHODS: The in vivo examination of five mice were performed on a preclinical MPI scanner and a 7 Tesla preclinical MRI system. MRI measurements were used for anatomical referencing and validation of the injection of superparamagnetic iron oxide (SPIO) particles during a dynamic MPI scan. We extracted MPI data of the injection phase and co-registered it with MRI data.RESULTS: A workflow process for a combined in vivo MRI and MPI examination was established. A successful injection of ferucarbotran was proven in MPI and MRI. MR-MPI co-registration allocated the SPIOs in the inferior vena cava and the heart during and shortly after the injection.CONCLUSION: The acquisition of preclinical MPI and MRI data is feasible and allows the combined analysis of MR-MPI information.",
keywords = "Animals, Blood Flow Velocity, Dextrans, Image Enhancement, Image Interpretation, Computer-Assisted, Magnetic Resonance Angiography, Magnetite Nanoparticles, Mice, Multimodal Imaging, Pilot Projects, Reproducibility of Results, Sensitivity and Specificity, Subtraction Technique, Vena Cava, Inferior, Workflow",
author = "Kaul, {M G} and O Weber and U Heinen and A Reitmeier and T Mummert and C Jung and N Raabe and T Knopp and H Ittrich and G Adam",
note = "{\textcopyright} Georg Thieme Verlag KG Stuttgart · New York.",
year = "2015",
month = may,
doi = "10.1055/s-0034-1399344",
language = "English",
volume = "187",
pages = "347--52",
journal = "ROFO-FORTSCHR RONTG",
issn = "1438-9029",
publisher = "Georg Thieme Verlag KG",
number = "5",

}

RIS

TY - JOUR

T1 - Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice

AU - Kaul, M G

AU - Weber, O

AU - Heinen, U

AU - Reitmeier, A

AU - Mummert, T

AU - Jung, C

AU - Raabe, N

AU - Knopp, T

AU - Ittrich, H

AU - Adam, G

N1 - © Georg Thieme Verlag KG Stuttgart · New York.

PY - 2015/5

Y1 - 2015/5

N2 - PURPOSE: Magnetic particle imaging (MPI) is a new radiologic imaging modality. For the first time, a commercial preclinical scanner is installed. The goal of this study was to establish a workflow between MPI and magnetic resonance imaging (MRI) scanners for a complete in vivo examination of a mouse and to generate the first co-registered in vivo MR-MP images.MATERIALS AND METHODS: The in vivo examination of five mice were performed on a preclinical MPI scanner and a 7 Tesla preclinical MRI system. MRI measurements were used for anatomical referencing and validation of the injection of superparamagnetic iron oxide (SPIO) particles during a dynamic MPI scan. We extracted MPI data of the injection phase and co-registered it with MRI data.RESULTS: A workflow process for a combined in vivo MRI and MPI examination was established. A successful injection of ferucarbotran was proven in MPI and MRI. MR-MPI co-registration allocated the SPIOs in the inferior vena cava and the heart during and shortly after the injection.CONCLUSION: The acquisition of preclinical MPI and MRI data is feasible and allows the combined analysis of MR-MPI information.

AB - PURPOSE: Magnetic particle imaging (MPI) is a new radiologic imaging modality. For the first time, a commercial preclinical scanner is installed. The goal of this study was to establish a workflow between MPI and magnetic resonance imaging (MRI) scanners for a complete in vivo examination of a mouse and to generate the first co-registered in vivo MR-MP images.MATERIALS AND METHODS: The in vivo examination of five mice were performed on a preclinical MPI scanner and a 7 Tesla preclinical MRI system. MRI measurements were used for anatomical referencing and validation of the injection of superparamagnetic iron oxide (SPIO) particles during a dynamic MPI scan. We extracted MPI data of the injection phase and co-registered it with MRI data.RESULTS: A workflow process for a combined in vivo MRI and MPI examination was established. A successful injection of ferucarbotran was proven in MPI and MRI. MR-MPI co-registration allocated the SPIOs in the inferior vena cava and the heart during and shortly after the injection.CONCLUSION: The acquisition of preclinical MPI and MRI data is feasible and allows the combined analysis of MR-MPI information.

KW - Animals

KW - Blood Flow Velocity

KW - Dextrans

KW - Image Enhancement

KW - Image Interpretation, Computer-Assisted

KW - Magnetic Resonance Angiography

KW - Magnetite Nanoparticles

KW - Mice

KW - Multimodal Imaging

KW - Pilot Projects

KW - Reproducibility of Results

KW - Sensitivity and Specificity

KW - Subtraction Technique

KW - Vena Cava, Inferior

KW - Workflow

U2 - 10.1055/s-0034-1399344

DO - 10.1055/s-0034-1399344

M3 - SCORING: Journal article

C2 - 25962671

VL - 187

SP - 347

EP - 352

JO - ROFO-FORTSCHR RONTG

JF - ROFO-FORTSCHR RONTG

SN - 1438-9029

IS - 5

ER -